(Q48963855)

17 February 2018

title

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. (English)

1 reference

17 February 2018

0 references

6

1 reference

17 February 2018

author name string

A M Saunders

1

1 reference

17 February 2018

O Hulette

2

1 reference

17 February 2018

K A Welsh-Bohmer

3

1 reference

17 February 2018

D E Schmechel

4

1 reference

17 February 2018

B Crain

5

1 reference

17 February 2018

M J Alberts

7

1 reference

17 February 2018

W J Strittmatter

8

1 reference

17 February 2018

J C Breitner

9

1 reference

17 February 2018

C Rosenberg

10

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 July 1996

1 reference

17 February 2018

published in

The Lancet

1 reference

17 February 2018

volume

348

1 reference

17 February 2018

page(s)

90-93

1 reference

17 February 2018

issue

9020

1 reference

17 February 2018

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Genetic associations with human longevity at the APOE and ACE loci.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Clinical application of apolipoprotein E genotyping to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

APOE genotyping and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2901251-2

7 January 2021

10.1016/S0140-6736(96)01251-2

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

8676723

1 reference

17 February 2018